Merck Capital Ventures
North America, New Jersey, United States, Woodcliff Lake
Description
Merck Capital Ventures invests in companies in various stages of development from the first round of institutional funding to later stage
Investor Profile
Merck Capital Ventures has backed more than 15 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 13% of its total and boasts 7 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Series E rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, Canada.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Series B (20%)
- Series A (13%)
- Series E (13%)
- Series D (13%)
- Series C (13%)
- Series Unknown (13%)
- Seed (7%)
- Series F (7%)
Country Focus
- United States (87%)
- United Kingdom (7%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Canada (7%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Clinical Trials
- Data Integration
- Web Browsers
- Pharmaceutical
- Genetics
- Health Diagnostics
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
